0001113232 false 0001113232 2021-08-04 2021-08-04 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): August 4, 2021

 

Axcelis Technologies, Inc.

(Exact name of registrant as specified in its charter)

 

Delaware   000-30941   34-1818596
(State or other jurisdiction   (Commission   (IRS Employer
of incorporation)   File Number)   Identification No.)

 

108 Cherry Hill Drive, Beverly, Massachusetts   01915
(Address of principal executive offices)   (Zip Code)

 

Registrant’s telephone number, including area code: (978) 787-4000

 

(Former name or former address, if changed since last report.)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2.):

 

¨Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
  
¨Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
  
¨Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
  
¨Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933(§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company ¨

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class Trading Symbol(s) Name of each exchange on which registered
Common Stock, par value $0.001 per share ACLS NASDAQ Global Select Market

 

 

 

 

 

Item 2.02 Results of Operations and Financial Condition

 

On August 4, 2021, Axcelis Technologies, Inc. (the “Company”) issued a press release regarding its financial results for its quarter ended June 30, 2021. The Company’s press release is attached as Exhibit 99.1 to this Current Report on Form 8-K and incorporated by reference herein.

 

Item 9.01   Financial Statements and Exhibits.

 

Exhibit No.   Description
99.1   Press Release dated August 4, 2021. Filed herewith.
104   Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

2

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Date: August 4, 2021 Axcelis Technologies, Inc.
   
  By: /s/ KEVIN J. BREWER
    Kevin J. Brewer
    Executive Vice President
    and Chief Financial Officer

 

3

 

Exhibit 99.1

 

News Release  

 

AXCELIS ANNOUNCES FINANCIAL RESULTS FOR SECOND QUARTER 2021

 

The Company Expects 2021 Revenue to Exceed $625M

 

BEVERLY, Mass. — August 4, 2021—Axcelis Technologies, Inc. (Nasdaq: ACLS), a lending supplier of enabling ion implantation solutions for the semiconductor industry, today announced financial results for the second quarter ended June 30, 2021.

 

Highlights for the second quarter are as follows:

 

·The Company reported second quarter revenue of $147.3 million, compared to $132.8 million for the first quarter of 2021. This includes quarterly system revenues above $100 million, the first time since 2004.

 

·Operating profit for the quarter was $24 million, compared to $20.3 million for the first quarter.

 

·Net income for the quarter was $18.9 million, or $0.55 per diluted share, compared to net income of $16.5 million, or $0.48 per diluted share for the first quarter.

 

·Gross margin for the quarter was 43.5%, compared to 42.5% in the first quarter.

 

·Cash, cash equivalents and restricted cash were $220.5 million on June 30, 2021, compared to $207.5 million on March 31, 2021, after the settlement of stuck repurchases of $13.4 million.

 

·Shipped multiple high current and high energy Purion and legacy implant systems to multiple fab locations for a leading foundry located in China.

 

·Shipped multiple Purion M™ Power Series SiC medium current and Purion XE™ Power Series SiC high energy implanters to several leading SiC power device manufacturers located in Asia and Europe.

 

President and CEO Mary Puma commented, “Axcelis delivered strong second quarter financial performance as a result of overall strength in the semiconductor industry combined with growing demand for our Purion™ implant products, especially in the high growth power device market. The rapid acceleration of the electrification of the automotive industry is creating substantial demand for power devices and image sensors, which is driving sustainable growth for the Purion product extensions specifically developed for these markets. As a result of these market trends and the traction of our Purion base products and product line extensions, Axcelis is on track to exceed $625 million in revenue for the full year 2021. The Company is well positioned for strong sustainable growth.”

 

Business Outlook

 

For the third quarter ending September 30, 2021, Axcelis expects revenues to be approximately $170 million. Gross margin in the third quarter is expected to be approximately 42.5%. Third quarter operating profit is forecasted to be approximately $32 million with earnings per diluted share of approximately $0.70. The Company also expects to exceed $625 million in revenue for the full year 2021.

 

 

 

News Release  

 

Second Quarter 2021 Conference Call

 

The Company will host a call to discuss the results for the second quarter on Thursday, August 5, 2021 at 8:30 am ET. The call will be available to interested listeners via an audio webcast that can be accessed through the Investors page of Axcelis' website at www.axcelis.com, or by dialing 866.588.8911 (707.294.1561 outside North America). Participants calling into the conference call will be requested to provide the company name, Axcelis Technologies, and Audience Passcode: 7664896. Webcast replays will be available for 30 days following the call.

 

Safe Harbor Statement

 

This press release and the conference call contain forward-looking statements under the Private Securities Litigation Reform Act safe harbor provisions. These statements, which include our expectations for spending in our industry and guidance for future financial performance, are based on management’s current expectations and should be viewed with caution. They are subject to various risks and uncertainties that could cause actual results to differ materially from those in the forward-looking statements, many of which are outside the control of the Company, including that customer decisions to place orders or our product shipments may not occur when we expect, that orders may not be converted to revenue in any particular quarter, or at all, whether demand will continue for the semiconductor equipment we produce or, if not, whether we can successfully meet changing market requirements, and whether we will be able to maintain continuity of business relationships with and purchases by major customers. Increased competitive pressure on sales and pricing, increases in material and other production costs that cannot be recouped in product pricing and instability caused by changing global economic, political or financial conditions could also cause actual results to differ materially from those in our forward-looking statements. These risks and other risk factors relating to Axcelis are described more fully in the most recent Form 10-K filed by Axcelis and in other documents filed from time to time with the Securities and Exchange Commission.

 

About Axcelis:

 

Axcelis (Nasdaq: ACLS), headquartered in Beverly, Mass., has been providing innovative, high-productivity solutions for the semiconductor industry for over 40 years. Axcelis is dedicated to developing enabling process applications through the design, manufacture and complete life cycle support of ion implantation systems, one of the most critical and enabling steps in the IC manufacturing process. Learn more about Axcelis at www.axcelis.com.

 

 

 

News Release  

 

Company Contacts

 

Investor Relations: 

Doug Lawson
978.787.9552

 

Editorial/Media: 

Maureen Hart
978.787.4266

 

 

 

News Release  

 

Axcelis Technologies, Inc.

Consolidated Statements of Operations

(In thousands, except per share amounts)

(Unaudited)

 

   Three months ended   Six months ended 
   June 30,   June 30, 
   2021   2020   2021   2020 
Revenue:                
Product  $140,156   $117,194   $266,765   $229,327 
Services   7,118    5,771    13,285    12,629 
Total revenue   147,274    122,965    280,050    241,956 
Cost of revenue:                    
Product   76,688    65,519    147,022    132,691 
Services   6,572    5,547    12,579    11,817 
Total cost of revenue   83,260    71,066    159,601    144,508 
Gross profit   64,014    51,899    120,449    97,448 
Operating expenses:                    
Research and development   16,623    16,040    32,308    30,646 
Sales and marketing   12,177    9,437    22,564    17,641 
General and administrative   11,217    10,041    21,230    19,077 
Total operating expenses   40,017    35,518    76,102    67,364 
Income from operations   23,997    16,381    44,347    30,084 
Other (expense) income:                    
Interest income   40    70    73    552 
Interest expense   (1,274)   (1,299)   (2,303)   (2,602)
Other, net   (15)   421    (1,168)   (199)
Total other expense   (1,249)   (808)   (3,398)   (2,249)
Income before income taxes   22,748    15,573    40,949    27,835 
Income tax provision   3,842    2,271    5,563    3,312 
Net income  $18,906   $13,302   $35,386   $24,523 
Net income per share:                    
Basic  $0.56   $0.40   $1.05   $0.74 
Diluted  $0.55   $0.39   $1.03   $0.72 
Shares used in computing net income per share:                    
Basic weighted average common shares   33,677    33,116    33,696    32,998 
Diluted weighted average common shares   34,311    33,958    34,473    34,023 

 

 

 

News Release  

 

Axcelis Technologies, Inc.

Consolidated Balance Sheets

(In thousands, except per share amounts)

(Unaudited)

 

   June 30,   December 31, 
   2021   2020 
ASSETS          
Current assets:          
Cash and cash equivalents  $219,731   $203,479 
Accounts receivable, net   79,544    86,865 
Inventories, net   192,321    161,076 
Prepaid expenses and other current assets   22,535    19,371 
Total current assets   514,131    470,791 
Property, plant and equipment, net   30,683    29,840 
Operating lease assets   7,626    4,542 
Finance lease assets, net   19,889    20,544 
Long-term restricted cash   755    753 
Deferred income taxes   51,386    57,851 
Other assets   36,170    40,303 
Total assets  $660,640   $624,624 
LIABILITIES AND STOCKHOLDERS’ EQUITY          
Current liabilities:          
Accounts payable  $40,695   $24,013 
Accrued compensation   14,906    24,562 
Warranty   4,690    4,280 
Income taxes   622    654 
Deferred revenue   34,112    21,221 
Current portion of finance lease obligation   864    756 
Other current liabilities   10,585    8,945 
Total current liabilities   106,474    84,431 
Long-term finance lease obligation   46,923    47,393 
Long-term deferred revenue   1,406    1,837 
Other long-term liabilities   11,735    9,361 
Total liabilities   166,538    143,022 
           
Stockholders’ equity:          
Common stock, $0.001 par value, 75,000 shares authorized; 33,657 shares issued and outstanding at June 30, 2021; 33,633 shares issued and outstanding at December 31, 2020   34    34 
Additional paid-in capital   561,680    570,102 
Accumulated deficit   (70,281)   (91,969)
Accumulated other comprehensive income   2,669    3,435 
Total stockholders’ equity   494,102    481,602 
Total liabilities and stockholders’ equity  $660,640   $624,624